SCHEMBL182803

SCHEMBL182803

COc1cccc(-c2ncnc3ccc(-c4cncc(C#N)c4)cc23)c1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 3/20 0.54
CYP1A2 P05177 10/20 0.48
CYP3A4 P08684 10/20 0.48
ALDH1A1 P00352 9/20 0.48
CLK4 Q9HAZ1 8/20 0.48
LMNA P02545 6/20 0.48
CYP2C19 P33261 6/20 0.48
USP2 O75604 6/20 0.48
HSD17B10 Q99714 5/20 0.48
CYP2D6 P10635 5/20 0.48
TSHR P16473 4/20 0.48
HIF1A Q16665 4/20 0.48
MAPK1 P28482 3/20 0.48
CYP2C9 P11712 4/20 0.46
IRAK4 Q9NWZ3 2/20 0.45
PIK3CD O00329 1/20 0.44
PIK3CA P42336 1/20 0.44
PIK3CB P42338 1/20 0.44
MTOR P42345 1/20 0.44
PIK3CG P48736 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL183384 0.83 PIK3CD (0.61) MAP4K4CYP1A2CYP3A4ALDH1A1CLK4
SCHEMBL182841 0.72 LMNA (0.49) MAP4K4CYP1A2CYP3A4ALDH1A1CLK4
SCHEMBL15587440 0.71 MAP4K4 (1.00) MAP4K4IRAK4
SCHEMBL183242 0.71 PIK3CD (0.58) MAP4K4CYP1A2CYP3A4ALDH1A1CLK4
SCHEMBL2980619 0.69 CYP11B1 (0.54) MAP4K4HSD17B10MAPK1KITKDM4E
SCHEMBL3120401 0.68 MAP4K4 (0.56) MAP4K4CYP1A2CYP3A4ALDH1A1CLK4
SCHEMBL183106 0.67 PIK3CD (0.65) MAP4K4CYP1A2CYP3A4ALDH1A1CLK4
SCHEMBL2204306 0.67 HPGDS (0.60) CYP1A2CYP3A4ALDH1A1CLK4LMNA
SCHEMBL18462160 0.67 CYP11B2 (0.53) MAP4K4CYP1A2RAF1
SCHEMBL182982 0.66 PIK3CD (0.61) MAP4K4CYP1A2CYP3A4ALDH1A1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049502-B1 2,4-SUBSTITUTED QUINAZOLINES AS LIPID KINASE INHIBITORS NOVARTIS AG (CH) 2012-01-04 EP claimed